2025年,医疗保险受益人可能为胰岛素支付更多的费用;专家敦促在12月7日之前计划转换。 Medicare beneficiaries may pay more for insulin in 2025; experts urge plan switch by Dec 7.

由于D部分计划的变化,医疗保险受益人在2025年面临胰岛素和其他药物的较高费用。 Medicare beneficiaries face higher costs for insulin and other drugs in 2025 due to changes in Part D plans. Toni是一名医疗保健专家,他建议成员在12月7日入学期限结束之前,找到新的计划。 Toni, a Medicare expert, advises members to find a new plan before the enrollment period ends on December 7. 她建议使用Medicare.gov来比较计划,重点是那些以最低共同付费覆盖胰岛素的计划,并满足2,000美元自付药物费用限额。 She recommends using Medicare.gov to compare plans, focusing on those that cover insulin at the lowest copay and meet the $2,000 out-of-pocket drug cost limit.